Role of oral cyclophosphamide in the treatment of giant cell arteritis
Rheumatology,  Clinical Article

Quartuccio L et al. – CYC may represent a useful option for patients requiring prolonged medium– to high–dose Glucocorticoid (GC) therapy and at high risk of GC–related side effects.

Methods
  • Nineteen patients treated with CYC were retrospectively analysed.
  • CYC was administered in 15 of the 19 patients after failure of high doses of GC or relapse during medium to high doses of GC, with or without MTX, while CYC was used ab initio in 4 of the 19 patients, all with type 2 diabetes.
  • Follow–up ranged from 1 month to nearly 9 years after the end of CYC treatment.

Results
  • The efficacy of CYC was observed in 15 of the 19 patients, and remission was still present 6–12 months after CYC suspension in 12 of the 13 patients.
  • GCs were suspended in 6 of the 15 patients, and they were continued at a dose ≤5 mg/day of prednisone in all the remaining responders.
  • Relapse occurred in 4 of the 15 patients, usually >12 months after CYC suspension.
  • Suspension of GC daily dose or reduction to ≤5 mg/day of prednisone occurred within the first 6 months of follow–up after the beginning of CYC in 10 of the 15 patients.
  • Ten adverse events were registered in nine patients, with recovery usually soon after the suspension of CYC or dose reduction.
  • However, one death occurred due to acute hepatitis.
  • Disappearance of the inflammatory infiltrate could be demonstrated when temporal artery biopsy was repeated 3 months after CYC in one patient.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Physician Assistant

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Physician Assistant Articles

1 Dance for Parkinson's: A new framework for research on its physical, mental, emotional, and social benefits Complementary Therapies in Medicine, June 17, 2014    Review Article

2 Statins in the elderly: an answered question Current Opinion in Cardiology, June 9, 2014    Evidence Based Medicine    Review Article    Clinical Article

3 Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the Physicians’ Health Study II randomized trial American Journal of Clinical Nutrition, July 10, 2014    Clinical Article

4 Consumption of nuts and legumes and risk of stroke: a meta-analysis of prospective cohort studies Nutrition, Metabolism & Cardiovascular Diseases, July 25, 2014    Evidence Based Medicine    Clinical Article

5 Calcium channel blocker compared with angiotensin receptor blocker for patients with hypertension: a meta-analysis of randomized controlled trials The Journal of Clinical Hypertension, August 13, 2014    Evidence Based Medicine    Review Article    Clinical Article

6 Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States BMJ, June 24, 2014    Evidence Based Medicine    Clinical Article

7 The effectiveness of metoprolol versus atenolol on prevention of all-cause and cardiovascular mortality in a large Chinese population: A cohort study International Journal of Cardiology, June 27, 2014    Clinical Article

8 A statin a day to keep the doctor away? comparing aspirin and statins for primary prevention of cardiovascular disease Annals of Pharmacotherapy, August 7, 2014    Clinical Article

9 New treatments for type 2 diabetes: Cardiovascular protection beyond glucose lowering Heart, Lung, and Circulation, September 4, 2014    Clinical Article

10 Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study American Journal of Clinical Nutrition, July 2, 2014    Clinical Article

11 Efficacy of high-dose versus standard-dose influenza vaccine in older adults New England Journal of Medicine, August 15, 2014    Evidence Based Medicine    Clinical Article

12 Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid Journal of Thrombosis and Haemostasis, September 25, 2014    Clinical Article

13 Efficacy and tolerability of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide: a subgroup analysis of patients stratified by hypertension severity, age, sex, and obesity The Journal of Clinical Hypertension, September 26, 2014    Clinical Article

14 Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer Journal of Clinical Oncology, September 26, 2014    Clinical Article

15 Short-term and long-term causes of death in patients with alcoholic hepatitis in Denmark Clinical Gastroenterology and Hepatology , September 26, 2014    Clinical Article

16 Cost effectiveness of response-guided therapy with peginterferon in the treatment of chronic hepatitis B Clinical Gastroenterology and Hepatology , September 26, 2014    Clinical Article

17 Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests Clinical Gastroenterology and Hepatology , September 26, 2014    Clinical Article

18 Risk factors for small-bowel mucosal breaks in chronic low-dose aspirin users: data from a prospective multicenter capsule endoscopy registry Gastrointestinal Endoscopy, September 26, 2014    Clinical Article

19 Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease Clinical Gastroenterology and Hepatology , September 26, 2014    Review Article

20 New insulin glargine 300 units·mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 units·mL-1 Diabetes Care, September 26, 2014    Clinical Article

Indexed Journals in Physician Assistant: Advance for Physicians Assistants, American Family Physicianmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close